Financial Ratios | Torrent Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent
BSE3349.60-12 (-0.36 %)
PREV CLOSE (Rs.) 3361.60
OPEN PRICE (Rs.) 3386.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2272
TODAY'S LOW / HIGH (Rs.)3296.00 3386.35
52 WK LOW / HIGH (Rs.)2025 3589.95
NSE3352.65-10.45 (-0.31 %)
PREV CLOSE( Rs. ) 3363.10
OPEN PRICE (Rs.) 3366.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3352.65 (95)
VOLUME 419534
TODAY'S LOW / HIGH(Rs.) 3295.00 3366.00
52 WK LOW / HIGH (Rs.)2025.7 3590.7

Financial Ratios

Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)48.9436.7945.9273.9760.55
   CEPS(Rs)72.8257.6742.5256.4249.61
   DPS(Rs)28.0022.0048.0035.0032.00
   Book NAV/Share(Rs)202.57183.13351.75344.90284.99
   Tax Rate(%)29.5832.5936.6017.9813.64
Margin Ratios
   Core EBITDA Margin(%)20.1317.3015.9816.6714.51
   EBIT Margin(%)16.2013.369.7412.6310.95
   Pre Tax Margin(%)14.0811.328.0610.267.94
   PAT Margin (%)9.927.635.118.416.85
   Cash Profit Margin (%)14.7511.969.4612.8411.23
Performance Ratios
   ROA(%)11.439.205.929.207.50
   ROE(%)25.3820.5013.1823.4921.47
   ROCE(%)24.2820.3214.3517.6215.28
   Asset Turnover(x)1.151.211.161.091.09
   Sales/Fixed Asset(x)1.271.391.431.431.48
   Working Capital/Sales(x)89.70-122.1820.2823.62-31.47
Efficiency Ratios
   Fixed Capital/Sales(x)0.790.720.700.700.68
   Receivable days41.3839.9937.8638.9237.65
   Inventory Days49.2652.4761.7159.2449.84
   Payable days279.66243.50306.08383.19381.76
Valuation Parameters
   PER(x)53.1541.7930.4517.1816.28
   PCE(x)35.7226.6632.8822.5219.87
   Price/Book(x)12.848.407.957.376.92
   Yield(%)1.081.431.721.381.62
   EV/Net Sales(x)8.505.905.995.904.85
   EV/Core EBITDA(x)26.6019.6619.3818.6216.82
   EV/EBIT(x)33.6826.0334.4025.1323.54
   EV/CE(x)8.444.944.043.462.84
   M Cap / Sales8.215.415.565.374.20
Growth Ratio
   Net Sales Growth(%)11.5113.076.290.823.47
   Core EBITDA Growth(%)18.659.873.5810.7112.33
   EBIT Growth(%)24.0847.24-21.1914.7853.68
   PAT Growth(%)33.0260.22-37.9222.17134.86
   EPS Growth(%)33.02-19.88-37.9222.17134.88
Financial Stability Ratios
   Total Debt/Equity(x)0.570.850.680.831.21
   Current Ratio(x)1.030.981.171.130.91
   Quick Ratio(x)0.620.570.620.590.52
   Interest Cover(x)7.656.545.815.323.63
   Total Debt/Mcap(x)0.040.100.080.110.18